化疗引起的胃肠道毒性:病原和当前的管理
Yunjing He1, Jingrui Zheng1, Binbin Ye1
1School of Chinese Materia Medica, Guangdong Pharmaceutical University, Guangzhou 510006, China.
Biochemical pharmacology
|September 4, 2023
概括
化疗导致胃肠道毒性 (CIGT),影响癌症患者的生活质量. 研究建议专注于肠道微生物群,神经毒性和中国传统医学 (TCM) 以更好地管理CIGT.
科学领域:
- 在瘤学瘤学.
- 胃肠病学 胃肠病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 化疗是一种主要的癌症治疗方法,但会引起显著的胃肠道毒性 (CIGT).
- CIGT对患者的生活质量产生负面影响,导致治疗不耐受.
- CIGT的机制复杂,涉及直接的粘膜损伤,肠道微生物群失调,炎症和神经毒性.
研究的目的:
- 综合审查CIGT.的病变发生.
- 总结CIGT目前的管理策略.
- 建议未来的研究方向,以优化CIGT干预.
主要方法:
- 使用PubMed和谷歌学者数据库进行文献评论.
- 综合关于CIGT病原和治疗方法的信息.
- 确定新兴的治疗目标和方法.
主要成果:
- 化疗剂直接损害了胃肠道.
- 肠道微生物群疾病,炎症和神经毒性是CIGT的关键因素.
- 传统中国医学 (TCM) 显示出作为CIGT的补充疗法具有前途.
结论:
- 未来的CIGT研究应该优先考虑肠道微生物群和肠道神经毒性.
- 探索TCM疗法为开发新型CIGT干预提供了一个有希望的途径.
- 优化CIGT管理需要采取多方面的方法来解决其复杂的病原性.
相关概念视频
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
242
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
242
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
198
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
198
Inflammatory Bowel Disease IV: Pharmacological Management
152
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
152
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
332
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
332
Prevention of Further Absorption of Poison
851
In cases of acute poisoning, the primary objective is to prevent further absorption of the toxic substance into the body. Immediate interventions using various decontamination techniques targeting the gastrointestinal (GI) tract can achieve this. Decontamination is crucial to prevent poison from entering the systemic circulation, which involves washing affected areas with water and mild soap and removing contaminated clothing. Once external decontamination is done, attention must be turned to...
851
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
195
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
195


